Pyrazole ether derivatives as anti-inflammatory/analgesic agents


The present invention relates to compounds of the formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, A, X and Y are defined as in the specification, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the invention are useful in the treatment or alleviation of inflammation and other inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.


< Substituted cycloalkyl P1' hepatitis C virus inhibitors

< Method of treating viral hepatitis by administration of liquid human -interferon

> Sustained release formulation containing tacrolimus

> Inhibitors of aspartyl protease

~ 00172